Scienture Holdings Faces Delisting Concerns
Ticker: SCNX · Form: 8-K · Filed: Oct 17, 2025 · CIK: 1382574
| Field | Detail |
|---|---|
| Company | Scienture Holdings, Inc. (SCNX) |
| Form Type | 8-K |
| Filed Date | Oct 17, 2025 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001, $1.00 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, corporate-action
TL;DR
Scienture Holdings might get delisted, big trouble ahead.
AI Summary
Scienture Holdings, Inc. (formerly TRxADE HEALTH, INC.) filed an 8-K on October 17, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and a transfer of listing. The filing date for this report was October 17, 2025, with the earliest event reported on October 14, 2025. The company is incorporated in Delaware and its principal business address is in Commack, NY.
Why It Matters
This filing indicates potential issues with Scienture Holdings' continued listing on an exchange, which could significantly impact its stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock and operations.
Key Players & Entities
- Scienture Holdings, Inc. (company) — Registrant
- TRxADE HEALTH, INC. (company) — Former company name
- October 14, 2025 (date) — Earliest event reported date
- October 17, 2025 (date) — Report date
- Delaware (jurisdiction) — State of incorporation
- Commack, NY (location) — Business address city and state
FAQ
What specific listing rule or standard has Scienture Holdings, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Scienture Holdings, Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the reason for the potential transfer of listing mentioned in the filing?
The filing states a 'Transfer of Listing' as an item of information, but does not provide the specific reasons or the destination exchange for this potential transfer.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on October 14, 2025.
What was Scienture Holdings, Inc. previously known as?
Scienture Holdings, Inc. was formerly known as TRxADE HEALTH, INC.
Where is Scienture Holdings, Inc. incorporated and what is its primary business address?
Scienture Holdings, Inc. is incorporated in Delaware and its business address is located at 20 AUSTIN BLVD., COMMACK, NY 11725.
Filing Stats: 592 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2025-10-17 17:00:38
Key Financial Figures
- $0.00001 — ch registered Common stock, par value $0.00001 per share SCNX The Nasdaq Stock Mar
- $1.00 — 00001 (" Common Stock ") had been below $1.00 per share for 30 consecutive business d
Filing Documents
- form8-k.htm (8-K) — 39KB
- 0001493152-25-018505.txt ( ) — 201KB
- scnx-20251014.xsd (EX-101.SCH) — 3KB
- scnx-20251014_lab.xml (EX-101.LAB) — 33KB
- scnx-20251014_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCIENTURE HOLDINGS, INC. By: /s/ Dr. Narasimhan Mani Dr. Narasimhan Mani Co-Chief Executive Officer Date: October 17, 2025